As of 2025-11-10, the Relative Valuation of Fate Therapeutics Inc (FATE) is (18.87) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.07 USD, the upside of Fate Therapeutics Inc based on Relative Valuation is -1863.9%.
The range of the Relative Valuation is (18.50) - (23.39) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.8x - 19.0x | 15.2x |
| Forward P/E multiples | 15.0x - 23.3x | 15.4x |
| Fair Price | (18.50) - (23.39) | (18.87) |
| Upside | -1829.3% - -2285.9% | -1863.9% |
| Date | P/E |
| 2025-11-07 | -0.87 |
| 2025-11-06 | -0.84 |
| 2025-11-05 | -0.88 |
| 2025-11-04 | -0.96 |
| 2025-11-03 | -1.02 |
| 2025-10-31 | -1.09 |
| 2025-10-30 | -1.05 |
| 2025-10-29 | -1.09 |
| 2025-10-28 | -1.21 |
| 2025-10-27 | -1.26 |
| 2025-10-24 | -1.34 |
| 2025-10-23 | -1.23 |
| 2025-10-22 | -1.21 |
| 2025-10-21 | -1.24 |
| 2025-10-20 | -1.25 |
| 2025-10-17 | -1.19 |
| 2025-10-16 | -1.25 |
| 2025-10-15 | -1.24 |
| 2025-10-14 | -1.22 |
| 2025-10-13 | -1.13 |
| 2025-10-10 | -1.33 |
| 2025-10-09 | -1.31 |
| 2025-10-08 | -1.22 |
| 2025-10-07 | -1.13 |
| 2025-10-06 | -1.14 |
| 2025-10-03 | -0.98 |
| 2025-10-02 | -0.98 |
| 2025-10-01 | -1.01 |
| 2025-09-30 | -1.02 |
| 2025-09-29 | -0.81 |
| 2025-09-26 | -0.81 |
| 2025-09-25 | -0.79 |
| 2025-09-24 | -0.82 |
| 2025-09-23 | -0.79 |
| 2025-09-22 | -0.82 |
| 2025-09-19 | -0.78 |
| 2025-09-18 | -0.81 |
| 2025-09-17 | -0.77 |
| 2025-09-16 | -0.77 |
| 2025-09-15 | -0.77 |
| 2025-09-12 | -0.78 |
| 2025-09-11 | -0.83 |
| 2025-09-10 | -0.81 |
| 2025-09-09 | -0.79 |
| 2025-09-08 | -0.78 |
| 2025-09-05 | -0.82 |
| 2025-09-04 | -0.79 |
| 2025-09-03 | -0.81 |
| 2025-09-02 | -0.83 |
| 2025-08-29 | -0.84 |